Post Market Study of the 3DKnee™ With E-plus Insert

TerminatedOBSERVATIONAL
Enrollment

175

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

January 31, 2022

Study Completion Date

January 31, 2022

Conditions
Degenerative Joint DiseaseOsteoarthritisTraumatic Arthritis
Interventions
DEVICE

3DKnee™ System with Vitamin E UHMWPE Tibial Inserts

This device is part of a total knee replacement system utilized in treating patients who are candidates for primary cemented total knee arthroplasty or revision arthroplasty where bone loss is minimal and the collateral ligaments are intact. It is intended to aid the surgeon in relieving the patient of knee pain and restoring knee joint function.

Trial Locations (6)

33919

Institute for Orthopaedic Surgery and Sports Medicine, Fort Myers

63376

St. Peter's Bone & Joint Surgery, City of Saint Peters

78751

Texas Institute for Hip and Knee Surgery, Austin

87106

New Mexico Orthopedics, Albuquerque

91505

Orthopaedic Surgery Specialists, Burbank

92056

Orthopedic Specialists of North County, Oceanside

Sponsors
All Listed Sponsors
collaborator

DJO Incorporated

INDUSTRY

lead

Encore Medical, L.P.

INDUSTRY

NCT01551472 - Post Market Study of the 3DKnee™ With E-plus Insert | Biotech Hunter | Biotech Hunter